AKZO NOBEL SPONS.ADRS 1/3 (AKUP) — Working Capital to Net Assets Ratio
AKZO NOBEL SPONS.ADRS 1/3 (AKUP) has a Working Capital to Net Assets ratio of 62.1% as of March 2026. Working capital of €3.14 Billion (current assets of €7.53 Billion minus current liabilities of €4.39 Billion) is measured against net assets of €5.05 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See AKZO NOBEL SPONS.ADRS 1/3 (AKUP) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
AKZO NOBEL SPONS.ADRS 1/3 Working Capital to Net Assets (2022–2025)
This chart shows how AKZO NOBEL SPONS.ADRS 1/3's Working Capital to Net Assets ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2026, the ratio stands at 62.1%, reflecting working capital of €3.14 Billion against net assets of €5.05 Billion EUR. Check AKUP intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for AKZO NOBEL SPONS.ADRS 1/3 (2022–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for AKZO NOBEL SPONS.ADRS 1/3 from 2022 to 2025, covering 4 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of AKZO NOBEL SPONS.ADRS 1/3.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 38.4% | €1.85 Billion | €4.82 Billion | €6.06 Billion | €4.21 Billion | ▲ +15.5 pp |
| 2024 | 23.0% | €1.11 Billion | €4.82 Billion | €5.84 Billion | €4.73 Billion | ▲ +15.5 pp |
| 2023 | 7.4% | €338.00 Million | €4.55 Billion | €6.04 Billion | €5.71 Billion | ▼ -3.5 pp |
| 2022 | 10.9% | €498.00 Million | €4.55 Billion | €6.24 Billion | €5.75 Billion | — |